What Is Periodic Alternating Nystagmus?
Periodic alternating nystagmus (PAN) is an involuntary, rhythmic oscillation of the eyes characterized by a horizontal jerk nystagmus that changes direction every one to two minutes. The cycle typically consists of a crescendo-decrescendo sequence in one direction, a brief neutral phase, and then a similar sequence in the opposite direction, repeating continuously. This condition can be congenital or acquired, and understanding its underlying neural mechanisms is essential for diagnosis and management.
Clinical Features and Detection
The hallmark of PAN is the periodic reversal of the fast phase. In a typical cycle, the nystagmus begins with a low-velocity beating toward one side, gradually increases in amplitude and frequency, then diminishes to a null period. Following a short quiescent interval of one to four seconds, the nystagmus reappears with the fast phase directed toward the opposite side. The entire cycle lasts approximately one to four minutes in most patients, although both shorter and longer cycles have been reported.
Because the direction changes are predictable, clinical evaluation with a stopwatch or video recording is often sufficient to identify PAN. Eye movement recordings from a specialized laboratory can confirm the diagnosis and distinguish PAN from other forms of nystagmus, such as congenital nystagmus without periodic alternation or gaze-evoked nystagmus.
Congenital Versus Acquired PAN
Congenital PAN typically appears in infancy or early childhood. It may occur in association with other visual or neurological abnormalities, including albinism, optic nerve hypoplasia, and aniridia. In many cases, however, congenital PAN occurs in otherwise healthy individuals with no identifiable ocular or systemic disease. The nystagmus may be asymptomatic or may cause mild reduction in visual acuity, which often improves with compensatory head postures or convergence.
Acquired PAN is more often linked to structural or metabolic lesions affecting the brainstem or cerebellum. Common causes include multiple sclerosis, stroke, tumor, trauma, Chiari malformation, and hepatic encephalopathy. Unlike the congenital form, acquired PAN frequently presents with oscillopsia (the sensation that the world is moving) and may be accompanied by other neurological deficits such as ataxia, vertigo, or cranial nerve palsies.
The Role of the Nodulus
A central structure involved in the generation of PAN is the cerebellar nodulus, located in the vestibulocerebellum. The nodulus receives direct input from vestibular afferents and modulates the velocity storage mechanism of the vestibular system. Velocity storage prolongs the time constant of the vestibulo-ocular reflex (VOR), allowing the brain to estimate head rotation over longer periods. In normal physiology, the nodulus inhibits velocity storage through GABAergic pathways, preventing excessive accumulation of vestibular signals.
In PAN, dysfunction of the nodulus or its related pathways causes the velocity storage mechanism to become unstable. This instability permits the slow-phase eye velocity to build up, decay, and reverse direction in a cyclical manner. Pharmacological and lesion studies in animal models have confirmed that ablation of the nodulus or uvula produces periodic alternating eye movements that closely resemble human PAN. These findings support the concept that the nodulus acts as a critical stabilizer of the vestibular system and that its impairment leads to the rhythmic alternation seen in this condition.
Treatment Considerations
Treatment of PAN depends on the underlying cause and the severity of symptoms. For acquired PAN, addressing the primary pathology—such as treating inflammation in multiple sclerosis or decompressing a Chiari malformation—may resolve the nystagmus. When no reversible cause is found, symptomatic therapy may be helpful. The most commonly used medication is the GABA-B agonist baclofen, which restores inhibitory control over the velocity storage mechanism. Many patients experience a marked reduction or complete suppression of the oscillation with oral baclofen, particularly when the nodulus is involved.
Congenital PAN may not require treatment if visual acuity is adequate and the patient does not experience oscillopsia. When symptoms warrant intervention, optical devices such as contact lenses or spectacles with specialized prisms can sometimes improve visual function. In refractory cases, extraocular muscle surgery or retrobulbar botulinum toxin injection has been attempted, but the long-term benefits are uncertain. A comprehensive neuro-ophthalmologic evaluation is recommended to guide management and to distinguish PAN from other nystagmus patterns.